Brief: Devyser Diagnostics Q4 EBIT Loss Widens To SEK 13.9 Million

Devyser Diagnostics AB

24/02/2022 07:36

Feb 24 (Reuters) - Devyser Diagnostics AB  DVYSR.ST :
    * DEVYSER DIAGNOSTICS AB PUBLISHES YEAR END REPORT FOR THE
PERIOD JANUARY TO DECEMBER 2021
    * Q4 NET SALES AMOUNTED TO SEK 24.5 MILLION (17.7),
CORRESPONDING
TO A 38.1 PERCENT INCREASE. ADJUSTED FOR EXCHANGE RATE
FLUCTUATIONS, NET SALES INCREASED BY 39.7 PERCENT.
    * Q4 GROSS PROFIT TOTALED SEK 18.5 MILLION (13.2),
CORRESPONDING
TO A GROSS MARGIN OF 75.3 PERCENT (74.3)
    * Q4 OPERATING LOSS (EBIT) AMOUNTED TO SEK -13.9 MILLION
(-10.1)
    * Q4 LOSS AFTER TAX TOTALED SEK -10.6 MILLION (-8.2).
    * BOARD IS NOT PROPOSING A DIVIDEND FOR 2021.

Source text for Eikon:  ID:nWkrDh0X1 
Further company coverage:  DVYSR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))